ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 173 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,756,000 | -44.3% | 543,063 | -38.7% | 0.46% | -42.9% |
| Q3 2016 | $12,137,000 | -20.0% | 886,561 | -56.8% | 0.80% | -26.1% |
| Q2 2016 | $15,168,000 | +35.5% | 2,052,525 | +17.2% | 1.08% | +30.6% |
| Q1 2016 | $11,194,000 | +12.5% | 1,751,813 | +10.0% | 0.83% | +16.8% |
| Q4 2015 | $9,953,000 | +26.4% | 1,592,527 | +18.1% | 0.71% | +11.5% |
| Q3 2015 | $7,873,000 | -23.7% | 1,348,195 | +8.0% | 0.64% | -31.3% |
| Q2 2015 | $10,320,000 | +21.8% | 1,247,917 | +21.4% | 0.93% | +5.1% |
| Q1 2015 | $8,473,000 | +7.0% | 1,028,263 | -10.8% | 0.88% | -13.5% |
| Q4 2014 | $7,917,000 | +122.4% | 1,152,466 | +74.8% | 1.02% | +9.6% |
| Q3 2014 | $3,560,000 | -11.0% | 659,232 | +5.0% | 0.93% | -14.6% |
| Q2 2014 | $4,000,000 | +70.6% | 627,968 | +115.9% | 1.09% | +7.7% |
| Q1 2014 | $2,345,000 | +79.1% | 290,886 | +51.5% | 1.01% | +7.2% |
| Q4 2013 | $1,309,000 | – | 191,965 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
| Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
| Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
| HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
| JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
| 1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
| Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
| Geduld E E | 185,100 | $1,157,000 | 0.72% |
| Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |